Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AK Medical HoldingsHKSE:01789 +1.31%97 EV-to-FCF is 13.20 as of Sep. 06, 2026, which is 72% below its 10-year median of 46.71. GuruFocus rates HKSE:01789 with a GF Score™ of 97/100 and a GF Value™ of HK$7.70 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 409 Medical Devices & Instruments companies, AK Medical Holdings ranks better than 75.79% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AK Medical Holdings's Enterprise Value is HK$3,948 Mil.
AK Medical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$299 Mil. Therefore, AK Medical Holdings's EV-to-FCF for today is 13.20.
The historical rank and industry rank for AK Medical Holdings's EV-to-FCF or its related term are showing as below:
HKSE:01789'
s EV-to-FCF Range Over the Past 10 Years
Min: -34.03 Med: 46.71 Max: 672.62
Current: 13.2
During the past 12 years, the highest EV-to-FCF of AK Medical Holdings was 672.62. The lowest was -34.03. And the median was 46.71.
HKSE:01789's EV-to-FCF is ranked better than 75.79% of 409
companies
in the Medical Devices & Instruments industry
Industry Median: 23.69
vs HKSE:01789: 13.20
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AK Medical Holdings (HKSE:01789) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AK Medical Holdings's PE Ratio (TTM) for today is calculated as:
AK Medical Holdings's share price for today is HK$5.015.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AK Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.333.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
AK Medical Holdings EV-to-FCF Related Terms
AK Medical Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for AK Medical Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AK Medical Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AK Medical Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where AK Medical Holdings's EV-to-FCF falls into.
AK Medical Holdings's current Enterprise Value is HK$3,948 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AK Medical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$299 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AK Medical Holdings (HKSE:01789) has a EV-to-FCF of 13.20 as of Sep. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on AK Medical Holdings and its competitors. This is 72% below median its historical median of 46.71. According to the industry distribution chart, AK Medical Holdings ranks #99 out of 409 companies in the Medical Devices & Instruments industry, placing it in the top 24.2%.
Is AK Medical Holdings' EV-to-FCF too high?
AK Medical Holdings' current EV-to-FCF of 13.20 is 72% below median its 10-year median of 46.71. The Medical Devices & Instruments industry median EV-to-FCF is 23.69. AK Medical Holdings' value of 13.20 is 44.3% below this industry median. Based on the distribution chart, AK Medical Holdings ranks #99 out of 409 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AK Medical Holdings has a GF Score™ of 97/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AK Medical Holdings' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, AK Medical Holdings ranks #99 out of 409 companies for EV-to-FCF. This places AK Medical Holdings in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.69. AK Medical Holdings' value of 13.20 is 44.3% below this benchmark. While the company's 10-year median is 46.71 vs. the industry median of 23.69, AK Medical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.69, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AK Medical Holdings's current EV-to-FCF of 13.20 is 44.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on AK Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AK Medical Holdings's current EV-to-FCF is 13.20, which is 72% below median its own 10-year median of 46.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AK Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, AK Medical Holdings (HKSE:01789) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$7.70, compared to a current price of HK$5.02 — trading 34.9% below its estimated fair value. The current EV-to-FCF is 13.20, which is 72% below median its 10-year median of 46.71 and 44.3% below the Medical Devices & Instruments industry median of 23.69. AK Medical Holdings' overall GF Score™ is 97/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For AK Medical Holdings (HKSE:01789), the current EV-to-FCF is 13.20 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AK Medical Holdings (HKSE:01789) Overvalued in 2026?
Based on GuruFocus' analysis, AK Medical Holdings stock appears to be undervalued.
The current stock price of HK$5.02 is trading 34.9% below its estimated GF Value™ of HK$7.70.
GuruFocus considers AK Medical Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:01789:
EV-to-FCF: 13.20 (72% below median its 10-year median of 46.71)
GF Value™: HK$7.70 vs. price of HK$5.02 (34.9% below fair value)
Industry Position: 44.3% below the Medical Devices & Instruments median (#99 of 409)
No single metric tells the full story. See the HKSE:01789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AK Medical Holdings Ltd is an investment holding company, along with a subsidiary, engaged in designing, developing, producing and marketing orthopedic implants and related products. The principal activities of the group are manufacturing and sale of orthopedic joint implants, spinal implants, trauma implants, and their complete set of surgical instruments. Its geographical segments are China and the United Kingdom. It derives the majority of its revenue from China. The company offers Products and technologies: hip joint products, Knee joint products, Spine and Trauma Products, Oncology products, Digital products, and ICOS Medical Engineering Interaction Technology.
97GF Score
Get the complete analysis for HKSE:01789
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01789 has been successfully added to your 
